drugset / Trial / NCT03456947

Pregabalin Stabilize Cardiovascular Response to Intubation

NCT03456947

Phase 4 Completed 90 enrolled Shanghai Zhongshan Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to evaluate whether Pregabalin is safe and effective in stabilizing cardiovascular response to laryngoscopy and tracheal intubation of patients under general anesthesia.

Timeline

Start
2017-01-01
Primary completion
2017-06-30
Completion
2017-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 150 mg Oral
Subject Pregabalin Small molecule 300 mg Oral

Indications

No indication recorded.